101 related articles for article (PubMed ID: 6609860)
1. Distinctive sensitivity of some T-leukemia cell lines to L-asparaginase.
Koishi T; Minowada J; Henderson ES; Ohnuma T
Gan; 1984 Mar; 75(3):275-83. PubMed ID: 6609860
[TBL] [Abstract][Full Text] [Related]
2. L-asparagine requirements of human T-lymphocytes and B-lymphocytes in culture.
Ohnuma T; Holland JF; Arkin H; Minowada J
J Natl Cancer Inst; 1977 Oct; 59(4):1061-3. PubMed ID: 302863
[TBL] [Abstract][Full Text] [Related]
3. The inhibition of lymphocyte blastogenesis by asparaginase: critical role of glutamine in both T and B lymphocyte transformation.
Kitoh T; Asai S; Akiyama Y; Kubota M; Mikawa H
Acta Paediatr Jpn; 1992 Dec; 34(6):579-83. PubMed ID: 1285501
[TBL] [Abstract][Full Text] [Related]
4. [Relationship between the antileukemic activity of L-asparaginase and Asn level around leukemic cells].
Li BS; Luo CY; He YY; Jiang H; Gu LJ
Zhongguo Dang Dai Er Ke Za Zhi; 2010 Jul; 12(7):557-62. PubMed ID: 20637156
[TBL] [Abstract][Full Text] [Related]
5. A genome-wide view of the in vitro response to l-asparaginase in acute lymphoblastic leukemia.
Fine BM; Kaspers GJ; Ho M; Loonen AH; Boxer LM
Cancer Res; 2005 Jan; 65(1):291-9. PubMed ID: 15665306
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid asparagine depletion during pegylated asparaginase therapy in children with acute lymphoblastic leukaemia.
Henriksen LT; Nersting J; Raja RA; Frandsen TL; Rosthøj S; Schrøder H; Albertsen BK;
Br J Haematol; 2014 Jul; 166(2):213-20. PubMed ID: 24702187
[TBL] [Abstract][Full Text] [Related]
7. An isocratic fluorescence HPLC assay for the monitoring of l-asparaginase activity and l-asparagine depletion in children receiving E. colil-asparaginase for the treatment of acute lymphoblastic leukaemia.
Nath CE; Dallapozza L; Eslick AE; Misra A; Carr D; Earl JW
Biomed Chromatogr; 2009 Feb; 23(2):152-9. PubMed ID: 18823071
[TBL] [Abstract][Full Text] [Related]
8. Differences in chemotherapeutic susceptibility of human T-, B-, and non-T-/non-B-lymphocytes in culture.
Ohnuma T; Arkin H; Holland JF
Recent Results Cancer Res; 1980; 75():61-7. PubMed ID: 6972072
[TBL] [Abstract][Full Text] [Related]
9. Asparaginase and amino acids in cancer therapeutics. Cancer and Leukemia Group B Investigators.
Holland JF; Ohnuma T
Cancer Treat Rep; 1981; 65 Suppl 4():123-30. PubMed ID: 7049376
[TBL] [Abstract][Full Text] [Related]
10. Taxotere and vincristine inhibit the secretion of the angiogenesis inducing vascular endothelial growth factor (VEGF) by wild-type and drug-resistant human leukemia T-cell lines.
Avramis IA; Kwock R; Avramis VI
Anticancer Res; 2001; 21(4A):2281-6. PubMed ID: 11724283
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of quinocarmycin (KW2152) against various cultured leukemia and lymphoma cell lines in vitro.
Inaba S; Shimoyama M
Cancer Res; 1988 Nov; 48(21):6029-32. PubMed ID: 3167853
[TBL] [Abstract][Full Text] [Related]
12. Determinants of deoxyadenosine toxicity in hybrids between human T- and B- lymphoblasts as a model for the development of drug resistance in T-cell acute lymphoblastic leukemia.
Kurtzberg J; Hershfield MS
Cancer Res; 1985 Apr; 45(4):1579-86. PubMed ID: 3872167
[TBL] [Abstract][Full Text] [Related]
13. Biochemical characterization of U937 cells resistant to L-asparaginase: the role of asparagine synthetase.
Kiriyama Y; Kubota M; Takimoto T; Kitoh T; Tanizawa A; Akiyama Y; Mikawa H
Leukemia; 1989 Apr; 3(4):294-7. PubMed ID: 2564453
[TBL] [Abstract][Full Text] [Related]
14. A phase I and pharmacodynamic evaluation of polyethylene glycol-conjugated L-asparaginase in patients with advanced solid tumors.
Taylor CW; Dorr RT; Fanta P; Hersh EM; Salmon SE
Cancer Chemother Pharmacol; 2001; 47(1):83-8. PubMed ID: 11221967
[TBL] [Abstract][Full Text] [Related]
15. L-Asparagine depletion levels and L-asparaginase activity in plasma of children with acute lymphoblastic leukemia under asparaginase treatment.
Tsurusawa M; Chin M; Iwai A; Nomura K; Maeba H; Taga T; Higa T; Kuno T; Hori T; Muto A; Yamagata M;
Cancer Chemother Pharmacol; 2004 Mar; 53(3):204-8. PubMed ID: 14634792
[TBL] [Abstract][Full Text] [Related]
16. Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296.
Winter SS; Holdsworth MT; Devidas M; Raisch DW; Chauvenet A; Ravindranath Y; Ducore JM; Amylon MD
Pediatr Blood Cancer; 2006 Feb; 46(2):179-86. PubMed ID: 16007607
[TBL] [Abstract][Full Text] [Related]
17. [Asparaginase].
Boiron M; Jacquillat C; Weil M; Tanzer J; Bernard J
Presse Med (1893); 1968 Nov; 76(44):2099-101. PubMed ID: 4882819
[No Abstract] [Full Text] [Related]
18. Selective apoptosis of natural killer-cell tumours by l-asparaginase.
Ando M; Sugimoto K; Kitoh T; Sasaki M; Mukai K; Ando J; Egashira M; Schuster SM; Oshimi K
Br J Haematol; 2005 Sep; 130(6):860-8. PubMed ID: 16156856
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of antineoplastic activity of extracellular asparaginase produced by isolated Bacillus circulans.
Prakasham RS; Hymavathi M; Subba Rao Ch; Arepalli SK; Venkateswara Rao J; Kennady PK; Nasaruddin K; Vijayakumar JB; Sarma PN
Appl Biochem Biotechnol; 2010 Jan; 160(1):72-80. PubMed ID: 19543838
[TBL] [Abstract][Full Text] [Related]
20. Synergistic Cytotoxic Effect of L-Asparaginase Combined with Decitabine as a Demethylating Agent in Pediatric T-ALL, with Specific Epigenetic Signature.
Serravalle S; Bertuccio SN; Astolfi A; Melchionda F; Pession A
Biomed Res Int; 2016; 2016():1985750. PubMed ID: 28003999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
